The PubMed entry indexed under PMID 43050477 corresponds to a 2026 PLoS One article titled "Intrapartum oral azithromycin versus placebo alone or in combination with other antimicrobials on maternal infection in South East Asia." The record lists a broad multinational authorship with lead contributors and collaborators from academic and public-health institutions across India, Bangladesh, Pakistan, Australia, and the United States. The DOI provided is 10.1371/journal.pone.0346359 and the article appears in the 2026 eCollection. The PubMed page in the captured content supplies full bibliographic metadata and author affiliations but does not include the body of the abstract or outcome data.
Authors’ affiliations enumerate multiple tertiary and research centers: sites in Maharashtra and Karnataka (India), Dhaka (Bangladesh), Karachi (Pakistan), Sydney (Australia), and U.S.-based academic centers among others. That distribution of institutions suggests the study was planned or executed with regional collaboration across South East Asia and with international academic partners. The PubMed entry documents those affiliations explicitly but does not provide site-level enrollment figures, center-specific roles, or ethics and registry identifiers in the excerpt provided here.
The title defines the trial comparison clearly: intrapartum oral azithromycin versus placebo, delivered either alone or combined with other antimicrobials, and the clinical focus is maternal infection in a South East Asian population. From that phrasing one can infer the investigators studied whether adding azithromycin during labor alters maternal infectious outcomes compared with placebo. The record, however, does not include the trial’s stated primary or secondary endpoints within the captured content, nor does it report the authors’ conclusions or effect estimates.
The PubMed excerpt supplied here omits the abstract text and study results. Consequently, the record as presented does not report several fundamental trial elements: sample size, randomization and allocation concealment, blinding procedures, dosing regimen for azithromycin (single dose versus multi-dose), timing of administration relative to delivery, whether the placebo arm received any standard prophylactic antibiotics, definitions used for maternal infection, follow-up duration, statistical analysis plan, or primary and secondary outcome measures. Safety data — including adverse-event rates, serious adverse events, or neonatal outcomes — are also not available in this captured content.
The absence of these details in the presented PubMed snapshot means that effect sizes, confidence intervals, p-values, and authors’ interpretations cannot be summarized from this source alone. The page functions primarily as an index record; it points to the full-text article via DOI but does not substitute for the article’s content.
Clinicians, systematic reviewers, and guideline authors require complete methodological and outcome data to assess internal validity, generalizability, and clinical relevance. The bibliographic record here signals that a randomized comparison may have been performed, but the PubMed entry as shown is insufficient to appraise risk of bias, magnitude of benefit or harm, or applicability to specific obstetric populations. To perform evidence synthesis, users must access the full-text article or at minimum the abstract and trial registry entry.
Until the full report is reviewed, practitioners should not change prophylactic intrapartum antibiotic practices based on this PubMed index alone. The record does not provide the necessary data to weigh antimicrobial benefits against potential harms such as selection for resistance, maternal adverse reactions, or neonatal effects.
The PubMed entry did not report the following items in the content provided here: dosing schedule and total dose of azithromycin, whether prophylactic antibiotics were routine in either arm, exact definitions and diagnostic criteria for maternal infection, timing of outcome assessment postpartum, sample size and power calculation, statistical outcomes, adverse-event reporting, or whether neonatal outcomes were included. The record also did not include registry numbers, funding sources in the excerpt, or explicit next regulatory or dissemination milestones.
These omissions are concrete. Investigators reported the trial title, authorship, affiliations, journal, DOI, and PMID in the indexed record, but the source did not provide methodological details or results in the captured PubMed content. To resolve these open questions, readers should retrieve the full PLoS One article via the DOI or consult trial registry entries linked from the published manuscript.
Limitations of this record
The limitation of the current PubMed snapshot is its role as an index rather than a content surrogate; it documents publication metadata but not the abstract or outcomes in the excerpt available here. The source did not report trial findings, effect estimates, or next steps within the captured content. Accessing the full-text article is required to complete clinical appraisal and to answer the operational and safety questions listed above.